Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
WITHDRAWN: Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.
Rijpkema S, Hockley J, Logan A, Rigsby P, Atkinson E, Jin C, Liang H, Bachtiar NS, Yang JS, Goel A, Ramasamy V, Pasetti MF; anti-Vi IgG working group. Rijpkema S, et al. Among authors: bachtiar ns. Biologicals. 2018 Jun 23:S1045-1056(18)30165-9. doi: 10.1016/j.biologicals.2018.05.007. Online ahead of print. Biologicals. 2018. PMID: 29941335 Free article. No abstract available.
Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.
Rijpkema S, Hockley J, Logan A, Rigsby P, Atkinson E, Jin C, Goldblatt D, Liang H, Bachtiar NS, Yang JS, Goel A, Ramasamy V, Pasetti MF, Pollard AJ; anti-Vi IgG working group. Rijpkema S, et al. Among authors: bachtiar ns. Biologicals. 2018 Nov;56:29-38. doi: 10.1016/j.biologicals.2018.09.001. Epub 2018 Sep 7. Biologicals. 2018. PMID: 30201529 Free PMC article.
Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies.
Rigsby P, Beamish E, Hockley J, Atkinson E, Hitri K, Jones E, Yang JS, Qadri F, Bachtiar NS, Elias SC, Goel A, Mishra R, Dugyala R, Pasetti MF, Meiring JE, Mbewe M, Gordon MA, Pollard AJ, Logan A, Rijpkema S; anti-Vi IgG working group. Rigsby P, et al. Among authors: bachtiar ns. Biologicals. 2020 Jul;66:21-29. doi: 10.1016/j.biologicals.2020.05.002. Epub 2020 Jun 20. Biologicals. 2020. PMID: 32571662 Free PMC article.
Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine.
Medise BE, Soedjatmiko S, Rengganis I, Gunardi H, Sekartini R, Koesno S, Satari HI, Hadinegoro SR, Yang JS, Excler JL, Sahastrabuddhe S, Puspita M, Sari RM, Bachtiar NS. Medise BE, et al. Among authors: bachtiar ns. PLoS One. 2019 Feb 13;14(2):e0211784. doi: 10.1371/journal.pone.0211784. eCollection 2019. PLoS One. 2019. PMID: 30759132 Free PMC article. Clinical Trial.
One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine.
Medise BE, Soedjatmiko S, Gunardi H, Sekartini R, Satari HI, Hadinegoro SR, Wirahmadi A, Puspita M, Sari RM, Yang JS, Sil A, Sahastrabuddhe S, Bachtiar NS. Medise BE, et al. Among authors: bachtiar ns. Int J Infect Dis. 2020 Apr;93:102-107. doi: 10.1016/j.ijid.2020.01.045. Epub 2020 Jan 28. Int J Infect Dis. 2020. PMID: 32004693 Free article. Clinical Trial.
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report.
Medise BE, Soedjatmiko S, Gunardi H, Sekartini R, Satari HI, Hadinegoro SR, Wirahmadi A, Puspita M, Sari RM, Yang JS, Sil A, Sahastrabuddhe S, Bachtiar NS. Medise BE, et al. Among authors: bachtiar ns. BMC Pediatr. 2020 Oct 15;20(1):480. doi: 10.1186/s12887-020-02375-4. BMC Pediatr. 2020. PMID: 33059607 Free PMC article. Clinical Trial.
The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule.
Rusmil K, Gunardi H, Fadlyana E, Soedjatmiko, Dhamayanti M, Sekartini R, Satari HI, Risan NA, Prasetio D, Tarigan R, Garheni R, Milanti M, Hadinegoro SR, Tanuwidjaja S, Bachtiar NS, Sari RM. Rusmil K, et al. Among authors: bachtiar ns. BMC Pediatr. 2015 Dec 19;15:219. doi: 10.1186/s12887-015-0525-2. BMC Pediatr. 2015. PMID: 26686508 Free PMC article. Clinical Trial.
DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months old.
Gunardi H, Rusmil K, Fadlyana E, Soedjatmiko, Dhamayanti M, Sekartini R, Tarigan R, Satari HI, Medise BE, Sari RM, Bachtiar NS, Kartasasmita CB, Hadinegoro SRS. Gunardi H, et al. Among authors: bachtiar ns. BMC Pediatr. 2018 May 28;18(1):177. doi: 10.1186/s12887-018-1143-6. BMC Pediatr. 2018. PMID: 29804542 Free PMC article. Clinical Trial.
34 results